FDA Import Refusal 1FX-6272166-6/30002/2 — ARVANTIS PHARMACEUTICALS
The FDA refused shipment 1FX-6272166-6/30002/2 from ARVANTIS PHARMACEUTICALS (India) on Jun 2, 2026. The refused product falls under Drugs and Biologics — ANTI-HISTAMINIC N.E.C.. Cited charge: 75
Refusal Details
- Date
- Jun 2, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61XDA99 ANTI-HISTAMINIC N.E.C.
- Charges
- 75